Home > Boards > Free Zone > User's Groups > $$$$$$$$ MICK, $Pistol Pete$ PINCHER CHART PLAYS $$$$$$$$

$CVSI BDS Analytics estimates that U.S. sales of

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
SpotOnTrade Member Profile
Member Level 
Followed By 807
Posts 134,224
Boards Moderated 8
Alias Born 08/13/10
160x600 placeholder
Top Stories of the Day
TOP STORIES Premier Foods Shares Seen as Undervalued -- Market Talk
Top Company News of the Day
Corn Futures Falls as Rainfall is Expected -- Daily Grain Highlights
Front Month Nymex Natural Gas Rose 10.51% This Week to Settle at $4.0600 -- Data Talk
Front Month Nymex RBOB Gasoline Rose 1.67% This Week to Settle at $2.2913 -- Data Talk
Grimmway Farms Recalls Certain Carrots Due to Risk of Salmonella
Kimberly-Clark Reports 2Q Results, Offers Guidance -- Commodity Comment
GDP Growth Expected to Accelerate in 2Q -- Data Week Ahead
Veoneer Shares Touch 52-week High, Magna Plans to Acquire Co.
AbbVie Gets FDA OK for Pediatric Skin Infection Drug
FTSE 100 Index Ends the Week 0.28% Higher at 7027.58 -- Data Talk
STOXX Europe 50 Index Ends the Week 0.84% Higher at 3558.08 -- Data Talk
CAC 40 Index Ends the Week 1.68% Higher at 6568.82 -- Data Talk
DAX Ends the Week 0.83% Higher at 15669.29 -- Data Talk
STOXX Europe 600 Index Ends the Week 1.49% Higher at 461.51 -- Data Talk
EURO STOXX 50 Index Ends the Week 1.82% Higher at 4109.10 -- Data Talk
FTSE 100 Closed Higher Despite Volatile Week
Vonovia Unlikely to Secure Enough Support From Deutsche Wohnen Shareholders to Pursue Takeover
Kimberly-Clark Keeps Forecast of Favorable FX in 2021 -- Currency Comment
U.S. Economic Growth Moderated in July -- IHS Markit
Veoneer Shares Climb on Magna Acquisition Deal
FTSE Rises, Covid-19 Strategy and Brexit Tensions Could Hit Pound
AstraZeneca's Bydureon BCise Gets U.S. Approval For Type 2 Diabetes in Pediatric Patients
SpotOnTrade Member Level  Saturday, 02/15/20 02:32:48 PM
Re: Hunchbackgeek post# 635
Post # of 662 
$CVSI BDS Analytics estimates that U.S. sales of cannabis and hemp-derived CBD product is expected to surge from $1.9 billion in 2018 to $20 billion by 2024, a compound annual growth rate of 49%. According to their research, there is substantial consumer interest in the consumables (tinctures, pills, beverages, food) and Topicals (creams, balms, salves) formats, despite the current low consumer penetration rate. In addition, many major national retailers (CVS, Walgreens, Rite Aid, Sprouts, Whole Foods, Ulta, GNC Holdings, Designer Brands, Urban Outfitters, and Neiman Marcus) have been early adopters of CBD topical products and have introduced various product lines in select markets.

Nothing I say, post, or do should ever be considered financial advice. I may be holding a long, short or no position. I am NOT or NEVER have I been compensated to post on here or anywhere and all my posts are for entertainment purposes only.
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences